FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296628485> ?p ?o ?g. }

• W4296628485 endingPage "100596" @default.
• W4296628485 startingPage "100596" @default.
• W4296628485 abstract "Non-invasive tests (NITs) offer a practical solution for advanced fibrosis identification in non-alcoholic fatty liver disease (NAFLD). Despite increasing implementation, their use is not standardised, which can lead to inconsistent interpretation and risk stratification. We aimed to assess the types of NITs and the corresponding cut-offs used in a range of healthcare settings.A survey was distributed to a convenience sample of liver health experts who participated in a global NAFLD consensus statement. Respondents provided information on the NITs used in their clinic with the corresponding cut-offs and those used in established care pathways in their areas.There were 35 respondents from 24 countries, 89% of whom practised in tertiary level settings. A total of 14 different NITs were used, and each respondent reported using at least one (median = 3). Of the respondents, 80% reported using FIB-4 and liver stiffness by vibration-controlled transient elastography (Fibroscan®), followed by the NAFLD fibrosis score (49%). For FIB-4, 71% of respondents used a low cut-off of <1.3 (range <1.0 to <1.45) and 21% reported using age-specific cut-offs. For Fibroscan®, 21% of respondents used a single liver stiffness cut-off: 8 kPa in 50%, while the rest used 7.2 kPa, 7.8 kPa and 8.7 kPa. Among the 63% of respondents who used lower and upper liver stiffness cut-offs, there were variations in both values (<5 to <10 kPa and >7.5 to >20 kPa, respectively).The cut-offs used for the same NITs for NAFLD risk stratification vary between clinicians. As cut-offs impact test performance, these findings underscore the heterogeneity in risk-assessment and support the importance of establishing consistent guidelines on the standardised use of NITs in NAFLD management.Owing to the high prevalence of non-alcoholic fatty liver disease (NAFLD) in the general population it is important to identify those who have more advanced stages of liver fibrosis, so that they can be properly treated. Non-invasive tests (NITs) provide a practical way to assess fibrosis risk in patients. However, we found that the cut-offs used for the same NITs vary between clinicians. As cut-offs impact test performance, these findings highlight the importance of establishing consistent guidelines on the standardised use of NITs to optimise clinical management of NAFLD." @default.
• W4296628485 created "2022-09-23" @default.
• W4296628485 creator A5000313377 @default.
• W4296628485 creator A5009242334 @default.
• W4296628485 creator A5009873146 @default.
• W4296628485 creator A5017525133 @default.
• W4296628485 creator A5023558309 @default.
• W4296628485 creator A5033881303 @default.
• W4296628485 creator A5039389628 @default.
• W4296628485 creator A5052059601 @default.
• W4296628485 creator A5052604947 @default.
• W4296628485 creator A5058384668 @default.
• W4296628485 creator A5058541785 @default.
• W4296628485 creator A5059068278 @default.
• W4296628485 creator A5063057369 @default.
• W4296628485 creator A5063641321 @default.
• W4296628485 creator A5070970519 @default.
• W4296628485 creator A5076455574 @default.
• W4296628485 creator A5080386622 @default.
• W4296628485 creator A5081426348 @default.
• W4296628485 creator A5086363081 @default.
• W4296628485 creator A5090087138 @default.
• W4296628485 creator A5090959657 @default.
• W4296628485 creator A5091620489 @default.
• W4296628485 date "2023-01-01" @default.
• W4296628485 modified "2023-10-17" @default.
• W4296628485 title "Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice" @default.
• W4296628485 cites W2067740038 @default.
• W4296628485 cites W2139654088 @default.
• W4296628485 cites W2529915765 @default.
• W4296628485 cites W2529917894 @default.
• W4296628485 cites W2734724639 @default.
• W4296628485 cites W2805865577 @default.
• W4296628485 cites W2934024125 @default.
• W4296628485 cites W3006195986 @default.
• W4296628485 cites W3008153721 @default.
• W4296628485 cites W3107442854 @default.
• W4296628485 cites W3162773903 @default.
• W4296628485 cites W3173706481 @default.
• W4296628485 cites W3174905293 @default.
• W4296628485 cites W3208129759 @default.
• W4296628485 cites W4206666977 @default.
• W4296628485 cites W4280528077 @default.
• W4296628485 cites W4292444185 @default.
• W4296628485 doi "https://doi.org/10.1016/j.jhepr.2022.100596" @default.
• W4296628485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36644239" @default.
• W4296628485 hasPublicationYear "2023" @default.
• W4296628485 type Work @default.
• W4296628485 citedByCount "5" @default.
• W4296628485 countsByYear W42966284852023 @default.
• W4296628485 crossrefType "journal-article" @default.
• W4296628485 hasAuthorship W4296628485A5000313377 @default.
• W4296628485 hasAuthorship W4296628485A5009242334 @default.
• W4296628485 hasAuthorship W4296628485A5009873146 @default.
• W4296628485 hasAuthorship W4296628485A5017525133 @default.
• W4296628485 hasAuthorship W4296628485A5023558309 @default.
• W4296628485 hasAuthorship W4296628485A5033881303 @default.
• W4296628485 hasAuthorship W4296628485A5039389628 @default.
• W4296628485 hasAuthorship W4296628485A5052059601 @default.
• W4296628485 hasAuthorship W4296628485A5052604947 @default.
• W4296628485 hasAuthorship W4296628485A5058384668 @default.
• W4296628485 hasAuthorship W4296628485A5058541785 @default.
• W4296628485 hasAuthorship W4296628485A5059068278 @default.
• W4296628485 hasAuthorship W4296628485A5063057369 @default.
• W4296628485 hasAuthorship W4296628485A5063641321 @default.
• W4296628485 hasAuthorship W4296628485A5070970519 @default.
• W4296628485 hasAuthorship W4296628485A5076455574 @default.
• W4296628485 hasAuthorship W4296628485A5080386622 @default.
• W4296628485 hasAuthorship W4296628485A5081426348 @default.
• W4296628485 hasAuthorship W4296628485A5086363081 @default.
• W4296628485 hasAuthorship W4296628485A5090087138 @default.
• W4296628485 hasAuthorship W4296628485A5090959657 @default.
• W4296628485 hasAuthorship W4296628485A5091620489 @default.
• W4296628485 hasBestOaLocation W42966284852 @default.
• W4296628485 hasConcept C119060515 @default.
• W4296628485 hasConcept C126322002 @default.
• W4296628485 hasConcept C141071460 @default.
• W4296628485 hasConcept C160735492 @default.
• W4296628485 hasConcept C162324750 @default.
• W4296628485 hasConcept C17744445 @default.
• W4296628485 hasConcept C199539241 @default.
• W4296628485 hasConcept C2776640315 @default.
• W4296628485 hasConcept C2778772119 @default.
• W4296628485 hasConcept C2779134260 @default.
• W4296628485 hasConcept C2780559512 @default.
• W4296628485 hasConcept C2780826214 @default.
• W4296628485 hasConcept C2994217296 @default.
• W4296628485 hasConcept C50522688 @default.
• W4296628485 hasConcept C71924100 @default.
• W4296628485 hasConceptScore W4296628485C119060515 @default.
• W4296628485 hasConceptScore W4296628485C126322002 @default.
• W4296628485 hasConceptScore W4296628485C141071460 @default.
• W4296628485 hasConceptScore W4296628485C160735492 @default.
• W4296628485 hasConceptScore W4296628485C162324750 @default.
• W4296628485 hasConceptScore W4296628485C17744445 @default.
• W4296628485 hasConceptScore W4296628485C199539241 @default.
• W4296628485 hasConceptScore W4296628485C2776640315 @default.
• W4296628485 hasConceptScore W4296628485C2778772119 @default.

• next